Logo image of CAMT

CAMTEK LTD (CAMT) Stock Fundamental Analysis

NASDAQ:CAMT - Nasdaq - IL0010952641 - Common Stock

103.62  +4.68 (+4.73%)

Premarket: 105.71 +2.09 (+2.02%)

Fundamental Rating

6

CAMT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 109 industry peers in the Semiconductors & Semiconductor Equipment industry. While CAMT has a great profitability rating, there are some minor concerns on its financial health. CAMT is valued quite expensive, but it does show an excellent growth. These ratings could make CAMT a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year CAMT was profitable.
Each year in the past 5 years CAMT has been profitable.
Each year in the past 5 years CAMT had a positive operating cash flow.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.63%, CAMT is in the better half of the industry, outperforming 79.63% of the companies in the same industry.
CAMT's Return On Equity of 20.69% is amongst the best of the industry. CAMT outperforms 86.11% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.87%, CAMT belongs to the top of the industry, outperforming 82.41% of the companies in the same industry.
CAMT had an Average Return On Invested Capital over the past 3 years of 11.38%. This is in line with the industry average of 11.96%.
The 3 year average ROIC (11.38%) for CAMT is below the current ROIC(11.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.63%
ROE 20.69%
ROIC 11.87%
ROA(3y)10.71%
ROA(5y)10.52%
ROE(3y)19.29%
ROE(5y)16.71%
ROIC(3y)11.38%
ROIC(5y)11.46%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

CAMT has a better Profit Margin (26.53%) than 88.89% of its industry peers.
In the last couple of years the Profit Margin of CAMT has grown nicely.
CAMT has a better Operating Margin (23.91%) than 84.26% of its industry peers.
CAMT's Operating Margin has improved in the last couple of years.
CAMT has a Gross Margin of 47.80%. This is comparable to the rest of the industry: CAMT outperforms 59.26% of its industry peers.
In the last couple of years the Gross Margin of CAMT has remained more or less at the same level.
Industry RankSector Rank
OM 23.91%
PM (TTM) 26.53%
GM 47.8%
OM growth 3Y13.43%
OM growth 5Y5.43%
PM growth 3Y21.29%
PM growth 5Y10.39%
GM growth 3Y-0.12%
GM growth 5Y-1.05%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CAMT is destroying value.
The number of shares outstanding for CAMT has been increased compared to 1 year ago.
Compared to 5 years ago, CAMT has more shares outstanding
CAMT has a better debt/assets ratio than last year.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 10.66 indicates that CAMT is not in any danger for bankruptcy at the moment.
CAMT has a better Altman-Z score (10.66) than 78.70% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that CAMT is not too dependend on debt financing.
CAMT's Debt to Equity ratio of 0.38 is on the low side compared to the rest of the industry. CAMT is outperformed by 65.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 10.66
ROIC/WACC0.85
WACC13.99%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

CAMT has a Current Ratio of 5.28. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
CAMT's Current ratio of 5.28 is amongst the best of the industry. CAMT outperforms 80.56% of its industry peers.
CAMT has a Quick Ratio of 4.36. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.36, CAMT is in the better half of the industry, outperforming 79.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.28
Quick Ratio 4.36
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.83% over the past year.
Measured over the past years, CAMT shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.44% on average per year.
CAMT shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.71%.
Measured over the past years, CAMT shows a very strong growth in Revenue. The Revenue has been growing by 20.69% on average per year.
EPS 1Y (TTM)38.83%
EPS 3Y44.97%
EPS 5Y27.44%
EPS Q2Q%47.06%
Revenue 1Y (TTM)29.71%
Revenue growth 3Y26.48%
Revenue growth 5Y20.69%
Sales Q2Q%39.6%

3.2 Future

CAMT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.18% yearly.
The Revenue is expected to grow by 19.11% on average over the next years. This is quite good.
EPS Next Y46.07%
EPS Next 2Y28.95%
EPS Next 3Y22.76%
EPS Next 5Y22.18%
Revenue Next Year35.51%
Revenue Next 2Y25.1%
Revenue Next 3Y19.46%
Revenue Next 5Y19.11%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 39.70 indicates a quite expensive valuation of CAMT.
60.19% of the companies in the same industry are more expensive than CAMT, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CAMT to the average of the S&P500 Index (27.94), we can say CAMT is valued slightly more expensively.
The Price/Forward Earnings ratio is 31.96, which means the current valuation is very expensive for CAMT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CAMT is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 24.11. CAMT is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 39.7
Fwd PE 31.96
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CAMT's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 41.34
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CAMT has an outstanding profitability rating, which may justify a higher PE ratio.
CAMT's earnings are expected to grow with 22.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.86
PEG (5Y)1.45
EPS Next 2Y28.95%
EPS Next 3Y22.76%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.28%, CAMT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.28, CAMT pays a better dividend. On top of this CAMT pays more dividend than 82.41% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, CAMT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

CAMT has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CAMT Yearly Dividends per shareCAMT Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y28.95%
EPS Next 3Y22.76%
CAMT Yearly Income VS Free CF VS DividendCAMT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

More info and screens

CAMTEK LTD

NASDAQ:CAMT (1/17/2025, 8:00:01 PM)

Premarket: 105.71 +2.09 (+2.02%)

103.62

+4.68 (+4.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)02-13 2025-02-13/amc
Inst Owners46.58%
Inst Owner Change-0.23%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap4.70B
Analysts85.71
Price Target110.54 (6.68%)
Short Float %13.58%
Short Ratio7.33
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.39%
Min EPS beat(2)0.71%
Max EPS beat(2)6.06%
EPS beat(4)4
Avg EPS beat(4)5.42%
Min EPS beat(4)0.71%
Max EPS beat(4)8.76%
EPS beat(8)7
Avg EPS beat(8)3.56%
EPS beat(12)9
Avg EPS beat(12)2.39%
EPS beat(16)13
Avg EPS beat(16)4.4%
Revenue beat(2)1
Avg Revenue beat(2)0.33%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)0.25%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)1.57%
Revenue beat(8)2
Avg Revenue beat(8)-0.38%
Revenue beat(12)3
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)0.45%
PT rev (1m)-0.57%
PT rev (3m)-7.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.53%
EPS NY rev (1m)0%
EPS NY rev (3m)3.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.26%
Valuation
Industry RankSector Rank
PE 39.7
Fwd PE 31.96
P/S 11.73
P/FCF N/A
P/OCF N/A
P/B 9.15
P/tB 11.06
EV/EBITDA 41.34
EPS(TTM)2.61
EY2.52%
EPS(NY)3.24
Fwd EY3.13%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.83
BVpS11.33
TBVpS9.37
PEG (NY)0.86
PEG (5Y)1.45
Profitability
Industry RankSector Rank
ROA 12.63%
ROE 20.69%
ROCE 13.16%
ROIC 11.87%
ROICexc 26.31%
ROICexgc 36.04%
OM 23.91%
PM (TTM) 26.53%
GM 47.8%
FCFM N/A
ROA(3y)10.71%
ROA(5y)10.52%
ROE(3y)19.29%
ROE(5y)16.71%
ROIC(3y)11.38%
ROIC(5y)11.46%
ROICexc(3y)41.1%
ROICexc(5y)40.46%
ROICexgc(3y)43.5%
ROICexgc(5y)42.07%
ROCE(3y)12.62%
ROCE(5y)12.7%
ROICexcg growth 3Y-14.44%
ROICexcg growth 5Y-8.43%
ROICexc growth 3Y-22.7%
ROICexc growth 5Y-13.87%
OM growth 3Y13.43%
OM growth 5Y5.43%
PM growth 3Y21.29%
PM growth 5Y10.39%
GM growth 3Y-0.12%
GM growth 5Y-1.05%
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 1.95
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.28
Quick Ratio 4.36
Altman-Z 10.66
F-ScoreN/A
WACC13.99%
ROIC/WACC0.85
Cap/Depr(3y)164.71%
Cap/Depr(5y)135.1%
Cap/Sales(3y)2.25%
Cap/Sales(5y)1.89%
Profit Quality(3y)82.16%
Profit Quality(5y)91.7%
High Growth Momentum
Growth
EPS 1Y (TTM)38.83%
EPS 3Y44.97%
EPS 5Y27.44%
EPS Q2Q%47.06%
EPS Next Y46.07%
EPS Next 2Y28.95%
EPS Next 3Y22.76%
EPS Next 5Y22.18%
Revenue 1Y (TTM)29.71%
Revenue growth 3Y26.48%
Revenue growth 5Y20.69%
Sales Q2Q%39.6%
Revenue Next Year35.51%
Revenue Next 2Y25.1%
Revenue Next 3Y19.46%
Revenue Next 5Y19.11%
EBIT growth 1Y39.52%
EBIT growth 3Y43.47%
EBIT growth 5Y27.24%
EBIT Next Year66.16%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.53%
FCF growth 3Y45.38%
FCF growth 5Y37.5%
OCF growth 1Y37.24%
OCF growth 3Y45.5%
OCF growth 5Y36.42%